Sponsored
Peter Belden, Tjoapack, discusses how the rise of specialized medicines for smaller patient populations is necessitating more flexible, redundant packaging capacity to manage complex global distribution requirements.
Peter Belden, Tjoapack
Advertisement
Articles by Peter Belden, Tjoapack
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5